Therapy Discogenic Cell Suppliers Serving Us Virgin Islands

Bertin Technologies is a French industrialist in scientific instrumentation that designs and manufactures, in France and in Europe, measurement, observation & detection systems and instruments for critical applications. Every day, Bertin ...

We develop cell therapies - at a dramatically increased speed, at lower cost, and with less R&D risk. Trailhead Biosystems merges developmental biology and cell therapeutics with cutting-edge hardware and computerized experimental design and ...

Hemostemix (TSX V:HEM; OTCQB:HMTXF) is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. Hemostemix’s proprietary platform technology is based on more ...

Advent Bioservices began activity as a cell therapy contract development & manufacturing organisation (CDMO) in 2016. We are currently managing the development of a state-of-the-art facility for multiproduct GMP production outside Sawston in ...

NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning based software, which addresses the key knowledge gaps in the prediction of bona fide immunogenic antigens for personalized cancer ...

As a leading Biologics CDMO we provide mammalian, microbial, and cell therapy services that combine innovation with manufacturing and process excellence, from development to product delivery. We specialize in the development and GMP manufacturing of ...

Our mission at Alcyomics is to provide novel solutions for the assessment of safety and efficacy of pharmaceuticals, cosmetics and chemicals. As a service provider Alcyomics aspires to take the lead in providing unique screening services enabling ...

Terumo Blood and Cell Technologies is a global leader in blood component, therapeutic apheresis and cellular technologies serving customers in more than 130 countries. As the only company with the unique combination of apheresis collections, manual ...

Since its establishment in 1975, JCR has been working on proprietary technology developments and creation of products in a manner to be 'one step ahead' of competitors at all times under its corporate philosophy, 'Contributing towards people's ...

T-Cure is a clinical-stage immuno-oncology company developing the next generation of T cell therapies for patients with solid tumors. It is committed to bringing new targets and therapies to the T-Cell Receptor (TCR) field that have a high ...

Our robots help the life science industry manufacture precision medicines for all patients. The world’s most advanced robotic system for pharma manufacturing; We believe in a world where every patient has access to next-gen, precision medicines. ...

Tactiva Therapeutics is an immuno-oncology company specializing in potent cancer immunotherapy using a dual T cell receptor ...

The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies. ARM promotes legislative, regulatory, reimbursement and ...

We design, develop and manufacture nanofibrous biomaterials for medical devices and regenerative medicine. Our technology platform is built on electrospinning and associated processing technologies. We are supporting clients with material ...

TQ Therapeutics GmbH is pioneering a novel approach to cell and gene therapy with its TQx platform, which transforms the production of cellular therapies into a rapid, automated process that occurs at the patient's side. This method leverages ...

Adaptimmune, a leader in T-cell therapy, has clinical trials ongoing for three wholly owned SPEAR T-cells (ADP-A2M4, ADP-A2M4CD8, and ADP-A2AFP) in multiple solid tumor indications. The Company's unique SPEAR (Specific Peptide Enhanced Affinity ...

Lorem Cytori is committed to providing meaningful and quality therapeutic options with broad utility that benefit patients and healthcare providers around the world. Whether it’s advancing our product and technology pipeline, performing clinical ...

When developing a matrix for matrix-assisted cell transplantation, researchers inevitably face the problem of choosing a biopolymeric matrix that must ensure the survival of the cells contained in it before and after their introduction into the ...

Alpha-1 Biologics was founded by Cynthia L. Bristow, PhD, in June, 2011 for the purpose of developing patented biotechnology related to the generation of immune cells from stem cells within the body to treat immunodeficiency with the following ...

U.S. Stem Cell, Inc. (OTC:USRM) is an emerging leader in the worldwide development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions. Based in Sunrise, Florida, the Company has developed a clinical ...